business
Forget the Headlines. This Is Where Bezos Is Actually Putting His Money.
Key takeaways
- This Is Where Bezos Is Actually Putting His Money. 24/7 Wall St.
- Altos Labs targets cellular rejuvenation based on Nobel-winning stem cell research, treating aging as a disease affecting cancer, neurodegeneration, and cardiovascular decline simultaneously.
- Own a durable cash compounder first, then fund speculative long-duration bets with what it produces.
Forget the Headlines. This Is Where Bezos Is Actually Putting His Money. 24/7 Wall St. Jeremy Phillips Wed, June 10, 2026 at 7:17 PM GMT+7 3 min read AMZN NVDA Quick Read Bezos sold over 1.25 million AMZN shares via pre-scheduled 10b5-1 plans, quietly redeploying capital into Altos Labs, a private longevity biotech.
Altos Labs targets cellular rejuvenation based on Nobel-winning stem cell research, treating aging as a disease affecting cancer, neurodegeneration, and cardiovascular decline simultaneously.
Own a durable cash compounder first, then fund speculative long-duration bets with what it produces. Most retirement accounts cannot absorb a decade of zero returns.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop